Company / Interest Expense per Share
Kura Oncology, Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.02
FY2023
5-year range
$0.00 / $0.02
FY2019-FY2023
Trend
+518.8%
vs FY2022
Sector context
#37 of 43
Health Care
What the data says
Interest Expense per Share changed +519% YoY in FY2023, a notable deviation from the 7-year average annual change of +51%.
Based on SEC 10-K filings.
0.02 in FY2023 with a 5-year CAGR of -5.2%.
Increased from $0.01 to $0.02 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +24.8%
- 5-Year CAGR
- -5.2%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 43This company $0.02 Sector average $18.61
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 518.8% year-over-year.
- Ranks #37 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2017.
- Lowest interest expense per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.02 | +518.8% |
| FY2022 | $0.00 | -45.2% |
| FY2021 | $0.01 | -42.7% |
| FY2020 | $0.01 | -21.2% |
| FY2019 | $0.01 | -49.8% |
| FY2018 | $0.03 | -27.9% |
| FY2017 | $0.04 | +23.9% |
| FY2016 | $0.03 | +629.7% |
As of FY2023 · SEC 10-K · Updated Mar 28, 2026